Hand, Foot, and Mouth Disease Treatment Market: Pin-Point Analysis for Changing Competitive Dynamics

Hand, Foot, and Mouth Disease Treatment Market: Introduction Hand, foot, and mouth disease (HFMD) is a contagious viral infection. It is a mild clinical syndrome that mostly affects infants and children. It can be cured within 7 to 10 days. The most common causative agents of hand, foot, and mouth disease are coxsackievirus A16 and enterovirus A71. A supportive treatment is generally recommended for hand, foot, and mouth disease. The disease is characterized by oral enanthem, maculopapular, and macular or vesicular rashes on the hands and feet. The virus causes rashes or blisters in the mouth and on the palms of hands, soles of feet, and blisters in the mouth at the back of throat Read Report Overview - https://www.transparencymarketresearch.com/hand-foot-and-mouth-diseasetreatment-market.html Key Drivers and Opportunities of Global Hand, Foot, and Mouth Disease Treatment Market Surge in number of pharmaceutical manufacturers with strong focus on research and development is a key factor that is likely to drive the market. Thus, several drug candidates are in clinical trial phase to manage the HFMD in its very early stages. Furthermore, a rise in health care expenditure drives the demand for research & development of biologics and biosimilars for the treatment of hand, foot, and mouth disease Hand, foot, and mouth disease is common in children under the age of 5. Thus, an increase in number of patients with HFMD and the potential for severe complications are likely to drive the drug discovery research in order to combat the infection. This, in turn, propels the market. For instance, according to an article published in Iranian Journal of Public Health, a study conducted during 2008 to 2015, the incidence of HFMD increased rapidly from 86.59/100,000 in 2009 to 203.16/100,000 in 2014. Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php? flag=B&rep_id=71358 The researcher discovered a potent small molecule that blocks the early stages of EV71 infection and opens up the potential for novel drugs for treatment. This, in turn, is projected to create significant opportunity in the market. However, limited use of certain drugs such as aspirin in children is likely restrain the market North America to Dominate Global Hand, Foot, and Mouth Disease Treatment Market In terms of region, the global hand, foot, and mouth disease treatment market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to dominate the global hand, foot, and mouth disease treatment market during the forecast period. Early approval of drugs, well-established healthcare infrastructure, and hub for key players are major factors boosting the market in the region. Request for TOC - https://www.transparencymarketresearch.com/sample/sample.php? flag=T&rep_id=71358 The hand, foot, and mouth disease treatment market in Asia Pacific is estimated to expand at a rapid pace during the forecast period. Increase in spending on foot and mouth disease is anticipated to drive

Turn static files into dynamic content formats.

Create a flipbook